Skip to content
healthcare.dev

Arixtra

NDC 67457-594, fondaparinux sodium, injection, solution, from Mylan Institutional LLC.

Product NDC
67457-594
Status
Listed
Labeler
Mylan Institutional LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021345
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67457-594 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FONDAPARINUX SODIUM7.5 mg/.6mL

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
67457-594-066745705940610 SYRINGE, GLASS in 1 CARTON (67457-594-06) / .6 mL in 1 SYRINGE, GLASS (67457-594-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d3b30c68-cf45-4b46-8ba6-72090f7ba01a
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67457-594

Use it

Look up 67457-594 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67457-594 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67457-594. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.